WASHINGTON, June 09, 2017 (GLOBE NEWSWIRE) — Nineteen patients who benefitted from treatment with Abiomed’s Impella heart pumps traveled to Washington, D.C. on June 8, 2017, to meet with elected officials and participate in a Congressional Briefing hosted by the MedTech Caucus, which supports the development of innovative technology. This […]
Author: Ken Dropiewski
BioTelemetry Reaches Key Milestone In Tender Offer For LifeWatch Corp
MALVERN, Pa. and ZUG, Switzerland, June 09, 2017 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that during the main offer period which ended on June 8, 2017, […]
Abbott (ABT) Declares 374th Consecutive Quarterly Dividend
ABBOTT PARK, Ill., June 9, 2017 /PRNewswire/ — The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 26.5 cents per share. This marks the 374th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 15, 2017, to […]
St. John Hospital & Medical Center 1st in U.S. to Treat High Risk Patient with New Heart Stent and Pump
DETROIT, June 2, 2017 /PRNewswire-USNewswire/ — Heart care experts at St. John Hospital & Medical Center (SJH&MC) are the first in the country to treat a high risk patient with the use of a heart pump and newly approved heart stent technology. The procedure was performed by SJH&MC cardiologist, Antonious Attallah, […]
BIOTRONIK Launches Edora Pacemaker Series with MRI AutoDetect Technology
LAKE OSWEGO, Ore., June 7, 2017 /PRNewswire/ — BIOTRONIK today announced the availability of the Edora line of devices, the company’s first available pacemaker series featuring BIOTRONIK’s MRI AutoDetect technology. Edora SR-T is the smallest MR conditional pacemaker with automated MRI detection capability available in the US with a volume of […]
InspireMD Announces Distribution Agreement For CGuard EPS In Poland
TEL AVIV, ISRAEL–(Marketwired – June 05, 2017) – InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed an agreement with Arteriae Sp. z o.o. sp.k, a leading medical […]
Europe’s LimFlow Hires a COO and Opens Bay Area Office
LimFlow Expands Senior Management Team And Opens Silicon Valley Office PARIS–(BUSINESS WIRE)–LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ischemia (CLI), a severe form of peripheral artery disease (PAD), today announced the expansion of the company’s senior management team. Sophie Humbert, PhD, has been appointed […]
HeartFlow Names Healthcare Industry Veteran Michael Buck as Executive Vice President and Chief Commercial Officer
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow Inc. has announced the appointment of seasoned healthcare leader Michael Buck as executive vice president and chief commercial officer. Effective immediately, Buck will be responsible for expanding and accelerating global market adoption of the company’s HeartFlow® FFRct Analysis, the first noninvasive technology to provide insight into […]
Will iFR and OCT be the New Gold Standard for Pre-Intervention Analysis?
By Ken Dropiewski A new technique may soon bring even more precision to interventional cardiology. Patients with known coronary lesions are being urged to undergo two additional tests before intervention. These diagnostic tools are Instant Wave-free ratio (iFR) and Optical Coherence Tomography (OCT), and they help cardiologist make important decisions […]
SecurAcath Receives NICE Recommendation: Highlights Massive Cost Savings from Improved Catheter Securement
PLYMOUTH, Minn.–(BUSINESS WIRE)–Interrad Medical, a privately held medical device company, announces the SecurAcath Subcutaneous Engineered Stabilization Device is now recommended by the National Institute for Health and Care Excellence (NICE). The SecurAcath underwent a detailed assessment under the Medical Technologies Evaluation Program. As a result, NICE has published guidance supporting […]



